This study has been conducted to assess the sensitivity of indocyanine green angiography (ICGA) in detecting choroidal neovascularization (CNV) in patients with age-related macular degeneration (ARMD) with occult CNV at fluorescein angiography (FA) and to establish their eligibility for laser photocoagulation. Three hundred eighty-three eyes of 355 consecutive patients with occult CNV at FA were studied by ICGA; occult CNV with or without pigment epithelial detachment (PED) were detected as well. Eligibility for laser treatment was established on the basis of the ICGA-guided CNV extension and localization. Out of 157 eyes (41%) with occult CNV and PED, 74 (47.1%) showed focal ICGA CNV, 35 eyes (22.3%) had plaque CNV. Thirty-five eyes with PED (22.3%) appeared serous without CNV, and in 13 eyes (8.3%) no CNV was detectable because of large hemorrhages. Out of the 226 eyes (59%) presenting occult CNV without PED, 94 eyes (41.6%) had plaque CNV, and 58 (25.7%) had focal CNV. In 74 eyes (32.7%), there was no detectable CNV or only an ill-defined ICGA appearance. ARMD with PED is closely associated with focal CNV, while plaque CNV is largely found in exudative ARMD without PED (p < 0.001). Considering all the cases examined by ICGA, CNV was evident in 261 eyes (68%) occult at FA. Extrafoveal CNV laser treatment was recommended for 103 eyes (27%). Our results suggest that ICGA may be useful in the diagnosis and management of ARMD with occult CNV at FA increasing the number of patients eligible for laser treatment.

Keywords:
Age-related macular degeneration, Occult choroidal neovascularization, Indocyanine green angiography
1.
Flower RW, Hocheheimer BF: Clinical infrared absorption angiography of the choroid (letter). Am J Ophthalmol 1972;73:458–459.
2.
Hayashi K, De Laey JJ: Indocyanine green angiography of choroidal neovascular membranes. Ophthalmologica 1985;190:30–39.
3.
Destro M, Puliafito CA: Indocyanine green videoangiography of choroidal neovascularization. Ophthalmology 1989;96:846–853.
4.
Scheider A, Schroedel C: High resolution indocyanine green angiography with scanning laser ophthalmoscope. Am J Ophthalmol 1989;108:458–459.
5.
Guyer DR, Puliafito CA, Monés JM, Friedman E, Chang W, Verdooner BS: Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology 1992;99:287–291.
6.
Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA: Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992;12:191–223.
7.
Scheider A, Kaboth A, Neuhauser L: Detection of subretinal neovascularization membranes with indocyanine green and infrared scanning laser ophthalmoscope. Am J Ophthalmol 1992;113:45–51.
8.
Kuck H, Inhoffen W, Schneider U, Kreissig I: Diagnosis of occult subretinal neovascularization in age-related macular degeneration by infrared scanning laser videoangiography. Retina 1993;13:36–39.
9.
Regillo CD, Benson WE, Maguire JI, Annesley WH: Indocyanine green angiography and occult choroidal neovascularization. Ophthalmology 1994;101:280–288.
10.
Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hope-Ross M, Orlock DR: Digital indocyanine-green videoangiography of occult choroidal neovascularization. Ophthalmology 1994;101:1727–1737.
11.
Chang T, Freund B, Green WR, Yannuzzi LA: Clinicopathologic correlation of indocyanine green angiography of occult choroidal neovascularization. Retina 1994;14:114–124.
12.
Yannuzzi LA, Sorenson JA, Guyer DR, Slakter JS, Chang B, Orlock D: Indocyanine green videoangiography: Current status. Eur J Ophthalmol 1994;4:69–81.
13.
Yannuzzi LA, Hope-Ross M, Slakter JS, Guyer DR, Sorenson JA, Orlock DA: Analysis of vascularized pigment epithelium detachments using indocyanine green videoangiography. Retina 1994;14:99–113.
14.
Slakter JS, Yannuzzi LA, Sorenson JA, Guyer DR, Orlock DA: A pilot study of indocyanine green videoangiography guided laser photocoagulation treatment of occult choroidal neovascularization. Arch Ophthalmol 1994;112:465–472.
15.
Ho AC, Yannuzzi LA, Guyer DR, Slakter JS, Sorenson JA, Orlock DA: Intraretinal leakage of indocyanine green dye. Ophthalmology 1994;101:534–541.
16.
Sorenson JA, Yannuzzi LA, Slakter JS, Guyer DR, Ho AC, Orlock DA: A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994;112:473–479.
17.
Reiche E, Duker JS, Puliafito CA: Indocyanine green angiography and choroidal neovascularization obscured by hemorrhage. Ophthalmology 1995;102:1871–1876.
18.
Lim JI, Strerberg P Jr, Capone A Jr, Aaberg TM, Gilman JP: Selective use of indocyanine green angiography for occult choroidal neovascularization. Am J Ophthalmol 1995;120:75–82.
19.
Introini U, Pece A, Brancato R: Indocyanine green angiography of pigment epithelium detachment in age-related macular degeneration. Invest Ophthalmol 1995;36(suppl): p 243.
20.
Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hanutsaha P, Spaide RF, Schwartz SG, Hirschfeld JM, Orlock DA: Classification of choroidal neovascularization by digital indocyanine green videoangiography. Ophthalmology 1996;103:2054–2060.
21.
Macular Photocoagulation Study Group: Argon laser photocoagulation for age-related macular degeneration. Arch Ophthalmol 1982;100:912–918.
22.
Coscas G, Soubrane G: Argon laser photocoagulation for juxtafoveal subretinal neovascular membranes in SMD: Randomized study. Am J Ophthalmol 1982;94:426–427.
23.
Moorfields Macular Study Group: Treatment of senile disciform degeneration: A single blind randomized trial by argon laser photocoagulation. Br J Ophthalmol 1982;66:745–753.
24.
Macular Photocoagulation Study Group: Krypton laser photocoagulation for neovascularized lesions of age-related macular degeneration. Arch Ophthalmol 1990;108:816–824.
25.
Freund KB, Yannuzzi LA, Sorenson JA: Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786–791.
26.
Khun D, Meunier I, Soubrane G, Coscas G: Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 1995;113:1392–1398.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.